Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Apr 7;16(7):1083.
doi: 10.3390/nu16071083.

Do Herbal Supplements and Probiotics Complement Antibiotics and Diet in the Management of SIBO? A Randomized Clinical Trial

Affiliations
Randomized Controlled Trial

Do Herbal Supplements and Probiotics Complement Antibiotics and Diet in the Management of SIBO? A Randomized Clinical Trial

Lucia Redondo-Cuevas et al. Nutrients. .

Abstract

Small intestinal bacterial overgrowth (SIBO) arises from dysbiosis in the small intestine, manifesting with abdominal symptoms. This study aims to assess the efficacy of combined antibiotic therapy, herbal supplements, probiotics, and dietary modifications in SIBO management. A total of 179 SIBO-diagnosed patients underwent clinical evaluation and breath testing. Patients were categorized into hydrogen (H2-SIBO) and methane (CH4-SIBO) groups. The control group received standard antibiotic therapy and a low-FODMAP diet, while the intervention group received additional herbal antibiotics, probiotics, and prebiotics. After treatment, both groups exhibited reduced gas levels, particularly in CH4-SIBO. Clinical remission rates were higher in the intervention group, especially in CH4-SIBO cases. Logistic regression analysis showed gas concentrations at diagnosis as significant predictors of treatment success. In conclusion, adjunctive herbal supplements and probiotics did not significantly impact gas levels, but showed potential for clinical improvement, especially in CH4-SIBO.

Keywords: FODMAP diet; Small Intestine Bacterial Overgrowth (SIBO); antibiotics; dietary supplements; herbal therapies; probiotics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Diagram of the timeline of patient treatment and follow-up.
Figure 2
Figure 2
Diagnosed probability of normalization after treatment, according to the binary logistic regression model, in relation to the initial concentration of exhaled methane (a) and hydrogen (b). Red: CH4-SIBO; Blue: H2-SIBO.

References

    1. Weiss G.A., Hennet T. Mechanisms and consequences of intestinal dysbiosis. Cell Mol. Life Sci. 2017;74:2959–2977. doi: 10.1007/s00018-017-2509-x. - DOI - PMC - PubMed
    1. Bamba S., Imai T., Sasaki M., Ohno M., Yoshida S., Nishida A., Takahashi K., Inatomi O., Andoh A. Altered gut microbiota in patients with small intestinal bacterial overgrowth. J. Gastroenterol. Hepatol. 2022;38:61–69. doi: 10.1111/jgh.16013. - DOI - PubMed
    1. Li J., Zhang R., Ma J., Tang S., Li Y., Li Y., Wan J. Mucosa-Associated Microbial Profile Is Altered in Small Intestinal Bacterial Overgrowth. Front. Microbiol. 2021;12:710940. doi: 10.3389/fmicb.2021.710940. - DOI - PMC - PubMed
    1. Bushyhead D., Quigley E.M. Small Intestinal Bacterial Overgrowth-Pathophysiology and Its Implications for Definition and Management. Gastroenterology. 2022;163:593–607. doi: 10.1053/j.gastro.2022.04.002. - DOI - PubMed
    1. Oana K., Shimizu K., Takada T., Makino H., Yamazaki M., Katto M., Ando M., Kurakawa T., Oishi K. Manipulating the growth environment through co-culture to enhance stress tolerance and viability of probiotic strains in the gastrointestinal tract. Appl. Environ. Microbiol. 2023;89:e0150223. doi: 10.1128/aem.01502-23. - DOI - PMC - PubMed

Publication types

LinkOut - more resources